Want to join the conversation?
$KSS posted a 17% increase in 2Q16 earnings, helped by lower SG&A expenses compared to 2Q15. Net income was $140MM or $0.77 per diluted share compared to $130MM or $0.66 per diluted share. Net sales fell 2% from last year to $4.2Bil. Adjusted net income was $221MM or $1.22 per diluted share versus $211MM or $1.07 per diluted share last year.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.